Translational landscape of glioblastoma immunotherapy for physicians: guiding clinical practice with basic scientific evidence

Despite recent advances in cancer therapeutics, glioblastoma (GBM) remains one of the most difficult cancers to treat in both the primary and recurrent settings. GBM presents a unique therapeutic challenge given the immune-privileged environment of the brain and the aggressive nature of the disease....

Descripción completa

Detalles Bibliográficos
Autores principales: Kreatsoulas, Daniel, Bolyard, Chelsea, Wu, Bill X., Cam, Hakan, Giglio, Pierre, Li, Zihai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188021/
https://www.ncbi.nlm.nih.gov/pubmed/35690784
http://dx.doi.org/10.1186/s13045-022-01298-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188021/
https://www.ncbi.nlm.nih.gov/pubmed/35690784
http://dx.doi.org/10.1186/s13045-022-01298-0

Ejemplares similares